Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Lift off!!!

<< Previous

Bullboard Posts

Next >>

Comment by inthnoon Nov 30, 2022 1:50pm

125 Views

Post# 35140428

RE:RE:RE:RE:RE:Lift off!!!

Well if your seasoned biotech friend sent you that information then you need to talk to that person rather than saying you just added and then complained when the sp is up....if you are really worried about the day to day then generally biotech is not for you unless you are a day trader. Nuff said and at least wait until the posters then if there is an uptick take your money and run and then you will no longer have your day to day worries.

<< Previous

Bullboard Posts

Next >>

How to decrease sector risk by owning hundreds of mineral assets